Reps Challenge FDA On Foreign Drug Monitoring After Recalls
Lawmakers on both sides of the aisle are questioning the U.S. Food and Drug Administration's ability to inspect foreign drug manufacturers after a series of recalls of foreign-made blood pressure drugs...To view the full article, register now.
Already a subscriber? Click here to view full article